Arbutus Biopharma (ABUS) Profit After Tax (QoQ) (2013 - 2026)
Arbutus Biopharma (ABUS) Profit After Tax (QoQ) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,140.12 Bn | 66,139.83 Bn | - |
| 2 | Nanobiotix | 1,912.79 Bn | 1,912.73 Bn | - |
| 3 | Akari Therapeutics | 1,022.34 Bn | 1,022.34 Bn | - |
| 4 | BeOne Medicines | 472.60 Bn | 467.81 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.34 Bn | 115.09 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.14 Bn | 61.39 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.79 Bn | 62.79 Bn | - |
| 8 | Argenx Se | 56.19 Bn | 51.00 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.50 Bn | 34.49 Bn | 959.66 Mn |
| 10 | Arbutus Biopharma | 859.36 Mn | 764.14 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4,617.97% |
| Dec 31, 2025 | 51.49% |
| Sep 30, 2025 | -406.86% |
| Jun 30, 2025 | 110.27% |
| Mar 31, 2025 | -95.95% |
| Dec 31, 2024 | 36.44% |
| Sep 30, 2024 | 0.40% |
| Jun 30, 2024 | -10.75% |
| Mar 31, 2024 | 7.44% |
| Dec 31, 2023 | 3.94% |
| Sep 30, 2023 | -17.61% |
| Jun 30, 2023 | -4.62% |
| Mar 31, 2023 | 23.71% |
| Dec 31, 2022 | -15.93% |
| Sep 30, 2022 | -30.17% |
| Jun 30, 2022 | 9.98% |
| Mar 31, 2022 | 26.57% |
| Dec 31, 2021 | -11.88% |
| Sep 30, 2021 | 1.02% |
| Jun 30, 2021 | -18.35% |